IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Beta Drugs Limited is an Pharmaceutical based company, located in Baddi, Beta Drugs Limited IPO size was 19.52 Cr. and was issued at 85.00 per share. The share of Beta Drugs Limited were listed at 101.95 per share and are currently trading at 2124.50 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
Beta Drugs operates in Pharmaceutical and Manufacturing Of Its Leading Anticancer Cyto-toxics. The Issue is listed on NSE EMERGE in Oct, 2017. Beta Drugs IPO size was 19.52 Cr. with Issue price of 85.00 .
Merchant Banker(s) of Beta Drugs IPO: Pantomath Capital Advisors Private Limited
Beta Drugs IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Beta Drugs IPO listed at a listing price of 101.95 against the offer price of 85.00.
The current market price of Beta Drugs is 2124.50.
Why Us?
